메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
한준구 (서울대학교 의과대학 방사선과학교실)
저널정보
대한영상의학회 대한방사선의학회지 대한방사선의학회지 제27권 제4호
발행연도
1991.1
수록면
453 - 457 (5page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Many patients with hepatocellualr carcioma(HCC) treated by surgical resectio experience recurrence sooner or later. The authors analyzed the angiographic features and survival data of patients treated by transarterial chemoembokization(TAE) after recurrence to evaluated the effectiveness of TAE on postoperative recurrent HCC, Sixty-nine patients with HCC were operated on before September 1989 and had recurrence. All were treated by TAE with a Lipiodol-Adriamycin mixture with or without Gelfoam embolization. Angiographic types of the recurrent HCC were the multinodular type in 57.1%, single nodular type in 27%, diffuse type in 12.7% and single nodular type with perinodal extension in 3.2%. One and two-year survival rates after recurrence were 65.8% and 43.4%, respectively, and were not significantly different from the 310 patients who were not operated on but had good liver function. A 2 year survival rate after surgery was 68.7% and significantly better than that of patients who were not operated on. With transarterial chemoembolization, the survival rate after recurrence was the same as that of patients who were not operated on. TAE can be the effective means of treating recurrent hepatocellular carcinoma.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0